U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07408154) titled 'Direct vs Standard SLT for Glaucoma: A Noninferiority Trial' on Feb. 06.
Brief Summary: This study compares two FDA-approved laser treatments for glaucoma: Direct Selective Laser Trabeculoplasty (DSLT) and Selective Laser Trabeculoplasty (SLT). Both procedures aim to lower eye pressure and prevent vision loss. DSLT is a newer, non-contact technique that may improve comfort and efficiency. Participants will be randomly assigned to receive either DSLT or SLT and followed for 12 months to assess eye pressure, safety, and treatment outcomes.
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
Open-angle Glaucoma (OAG...